VAERS Explorer
Back to explore

Report #2826531

Received Feb 17, 2025

Hospitalized
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
52 yrs
State
AZ
Recovered
Not recovered
Vaccinated
Sep 10, 2021
Onset
Jun 1, 2023
Days to onset
629
Hospital days
3

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH3FC3183—

Symptoms (3)

Computerised tomogramMagnetic resonance imagingRenal cell carcinoma

Symptom narrative

renal cell carcinoma; This is a spontaneous report received from a Consumer or other non HCP. A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Sep2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 52 years for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "mitral valve regurgitation" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ESTRADIOL; OXYBUTYNIN; GABAPENTIN; HYDROXYZINE; ROSUVASTATIN. Past drug history included: Keflex, reaction(s): "known allergies: Keflex", notes: known allergies: Keflex. Vaccination history included: BNT162b2 (Dose 2, single, Lot no EL9625, facility type vaccine: Workplace clinic), administration date: 25Jan2021, when the patient was 51-year-old, for COVID-19 immunization; BNT162b2 (Dose 1, single, Lot no EL3246, facility type vaccine: Workplace clinic), administration date: 04Jan2021, when the patient was 51-year-old, for COVID-19 immunization. The following information was reported: RENAL CELL CARCINOMA (caused and prolonged hospitalization, medically significant) with onset 01Jun2023, outcome "recovering". The patient was hospitalized and prolonged hospitalization for renal cell carcinoma (hospitalization duration: 3 day(s)). The patient underwent the following laboratory tests and procedures: Computerised tomogram: unknown results; Magnetic resonance imaging: unknown results. Therapeutic measures were taken as a result of renal cell carcinoma. Clinical course: Patient ended up with renal cell carcinoma and had a partial nephrectomy Sep2023. She had no history of cancer.

Medical history

Medical History/Concurrent Conditions: Hypertension; Lupus syndrome; Mitral valve disease

Other medications

LISINOPRIL; ESTRADIOL; OXYBUTYNIN; GABAPENTIN; HYDROXYZINE; ROSUVASTATIN

Lab data

Test Name: CT scan; Result Unstructured Data: Test Result:unknown results; Test Name: MRI; Result Unstructured Data: Test Result:unknown results